References
- GeertsWHBergqvistDPineoGFPrevention of Venous Thromboembolism: American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008381S453S18574271
- MollSMackmanNVenous thromboembolism: a need for more public awareness and research into mechanismsArterioscler Thromb Vasc Biol20082836736918296590
- CohenATTapsonVFBergmannJFENDORSE InvestigatorsVenous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional studyLancet200837138739418242412
- LapostolleFSurgetVBorronSWSevere pulmonary embolism associated with air travelN Engl J Med200134577978311556296
- FrancisCWClinical practice. Prophylaxis for thromboembolism in hospitalized medical patientsN Engl J Med20073561438144417409325
- HeitJASilversteinMDMohrDNPettersonTMO’FallonWMMeltonLJ3rdRisk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control studyArch Intern Med200016080981510737280
- WhiteRHThe epidemiology of venous thromboembolismCirculation2003107I4I812814979
- KearonCNatural history of venous thromboembolismCirculation2003107I22I3012814982
- RodgerMAKahnSRWellsPSIdentifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCMAJ200817941742618725614
- KahnSRThe post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosisJ Thromb Thrombolysis200621414816475040
- HaenenJHJanssenMCvan LangenHThe postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmographyJ Vasc Surg1999291071107610359941
- PrandoniPLensingAWCogoAThe long-term clinical course of acute deep venous thrombosisAnn Intern Med1996125178644983
- PengoVLensingAWPrinsMHIncidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismN Engl J Med20043502257226415163775
- FedulloPFAugerWRKerrKMRubinLJChronic thromboembolic pulmonary hypertensionN Engl J Med20013451465147211794196
- SingerDEAlbersGWDalenJEAmerican College of Chest PhysiciansAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest200813354659218252921
- LipGNieuwlaatRPistersRLaneDCrijnsHRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial FibrillationChest201013726327219762550
- SchnabelRBSullivanLMLevyDDevelopment of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyLancet200937373974519249635
- HylekEMAntithrombotic prophylaxis in elderly patients with atrial fibrillationSemin Thromb Hemost20093554855319787558
- LeviMHobbsFDJacobsonAKImproving antithrombotic management in patients with atrial fibrillation: current status and perspectivesSemin Thromb Hemost20093552754219787556
- PistersRde VosCBNieuwlaatRCrijnsHJUse and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigmsSemin Thromb Hemost20093555455919787559
- LeviMde PeuterORKamphuisenPWManagement strategies for optimal control of anticoagulation in patients with atrial fibrillationSemin Thromb Hemost20093556056719787560
- AndersonJLAdamsCDAntmanEMAmerican College of CardiologyAmerican Heart Association Task Force on Practice GuidelinesACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol200750115717601538
- VickreyBGRectorTSWickstromSLOccurrence of secondary ischemic events among persons with atherosclerotic vascular diseaseStroke20023390190611935034
- CannegieterSCTornMRosendaalFROral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complicationsJ Intern Med199924536937410356599
- American College of Cardiology/American Heart Association Task Force on Practice GuidelinesSociety of Cardiovascular AnesthesiologistsSociety for Cardiovascular Angiography and InterventionsSociety of Thoracic SurgeonsBonowROCarabelloBAKanuCACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation200611484231
- VahanianABaumgartnerHBaxJTask Force on the Management of Valvular Hearth Disease of the European Society of CardiologyESC Committee for Practice GuidelinesGuidelines on the management of valvular heart diseaseEur Heart J20072823026817259184
- HirshJGuyattGAlbersGWHarringtonRSchünemannHJAmerican College of Chest PhysicianAntithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008133110112
- EikelboomJWWeitzJIA replacement for warfarin: the search continuesCirculation200711613113317576860
- HirshJO’DonnellMEikelboomJWBeyond unfractionated heparin and warfarin: current and future advancesCirculation200711655256017664384
- FrydmanALow-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humansHaemostasis19962624388707165
- BickRLFrenkelEPWalengaJFareedJHoppensteadtDAUnfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical useHematol Oncol Clin North Am20051915115639107
- VeselyMRKelemenMDCardiac risk assessment: matching intensity of therapy to riskCardiol Clin200624677816326257
- WarkentinTEGreinacherAKosterALincoffAMTreatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008340S380S18574270
- ChaturvediVKarthikeyanGFondaparinux in acute coronary syndromesExpert Opin Drug Metab Toxicol200951615162319929450
- HarenbergJWehlingMCurrent and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIaSemin Thromb Hemost200834395718393142
- HaasSNew anticoagulants – towards the development of an “ideal” anticoagulantVasa200938132919229800
- WienenWStassenJMPriepkeHRiesUJHauelNAntithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosisJ Thromb Haemost200751237124217362226
- StangierJRathgenKStähleHGansserDRothWThe pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBr J Clin Pharmacol20076429230317506785
- ErikssonBISmithHYasothanUKirkpatrickPDabigatran etexilateNat Rev Drug Discov2008755755818591978
- HaasSNew oral Xa and IIa inhibitors: updates on clinical trial resultsJ Thromb Thrombolysis200825526017965837
- WolowaczSERoskellNSPlumbJMEconomic evaluation of dabigatran etexilate for the preventionof venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacementThromb Haemost201010336037120024501
- StangierJClemensAPharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitorClin Appl Thromb Hemost2009819 [Epub ahead of print]
- DahlOEDabigatran etexilate: A new oral thrombin inhibitortherapy20085111
- WienenWStassenJMPriepkeHRiesUJHauelNIn-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateThromb Haemost20079815516217598008
- ErikssonBIDahlOERosencherNRE-MODEL Study GroupOral dabigatran etexilate vs subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the REMODEL randomized trialJ thromb Haemost200752178218517764540
- ErikssonBIDahlOERosencherNRE-NOVATE Study GroupDabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialLancet200737094995617869635
- GinsbergJSDavidsonBLCompPCRE-MOBILIZE Writing CommitteeOral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgeryJ Arthroplasty2009241918534438
- FujiTFuijitaSUjihiraTSatoTDabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients, with a safety profile comparable to placeboJ Arthroplasty20091024 [Epub ahead of print].
- SchulmanSKearonCKakkarAKDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med20093612342235219966341
- QureshiAIFeldmannEGomezCRIntracranial atherosclerotic disease: an updateAnn Neurol20096673073820035502
- HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med200714685786717577005
- GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA20012852864287011401607
- ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and Investigators. Dabigatran versus Warfarin in Patients with Atrial FibrillationN Engl J Med20093611139115119717844
- GageBFCan we rely on RE-LY?N Engl J Med20093611200120219717843
- HerijgersPVerhammePImproving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?Eur Heart J2007282424242617890728
- Viles-GonzalezJFFusterVBadimonJJAtherothrombosis: a widespread disease with unpredictable and life-threatening consequencesEur Heart J2004251197120715246637
- TurpieAGDirect Factor Xa and direct thrombin inhibitors: a clinical trial updateCurr Opin Drug Discov Devel200912497508
- HolmesDRJrKereiakesDJKleimanNSCombining antiplatelet and anticoagulant therapiesJ Am Coll Cardiol2009549510919573725
- WeitzJIFactor Xa or thrombin: is thrombin a better target?J Thromb Haemost20075656717635711
- MackmanNTriggers, targets and treatments for thrombosisNature200845191491818288180